Analyst Consensus ?
ConsensusHold29 ratings
Bullish1137.9%
Neutral1655.2%
Bearish26.9%
FN2 Earnings Intelligence
Cintas Corporation analyst ratings
Cintas Corporation (CTAS) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$201.5Current
$23.44Low
$177.77Average
$250High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 12, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Jul 16, 2026 |
| UBS | Buy | Buy | Maintain | Jul 16, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 16, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 16, 2026 |
| B of A Securities | Buy | Neutral | Upgrade | Jul 16, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jun 15, 2026 |
| Citigroup | Sell | Sell | Maintain | Mar 31, 2026 |
| Stifel | Hold | Hold | Maintain | Mar 26, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Dec 17, 2025 |
| JP Morgan | Overweight | Overweight | Maintain | Sep 25, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 2, 2025 |
| Barclays | Overweight | Overweight | Maintain | Sep 27, 2024 |
| Jefferies | Hold | Hold | Maintain | Sep 26, 2024 |
| CFRA | Sell | Strong Sell | Maintain | Sep 12, 2024 |
| Oppenheimer | Perform | Perform | Maintain | Apr 1, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 28, 2024 |
| Argus Research | Buy | Buy | Maintain | Jul 14, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Jul 16, 2021 |
| William Blair | Market Perform | Outperform | Downgrade | Apr 6, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Sep 25, 2019 |
| Nomura | Neutral | Neutral | Maintain | Jul 22, 2019 |
| Bank of America | Buy | Neutral | Upgrade | Jan 3, 2019 |
| Nomura Instinet | Neutral | Buy | Downgrade | Jun 27, 2017 |
| Instinet | Neutral | Buy | Downgrade | Jun 27, 2017 |
| Keybanc | Overweight | Overweight | Maintain | Oct 3, 2016 |
| Macquarie | Neutral | Neutral | Maintain | Aug 25, 2016 |
| Sterne Agee CRT | Neutral | Neutral | Maintain | Mar 22, 2016 |
| PiperJaffray | Neutral | Neutral | Maintain | Nov 18, 2013 |
| Barrington Research | Market Perform | Outperform | Downgrade | Jul 17, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $201.5. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $230 | $203.66 | +14.1% | Jul 16, 2026 |
| Robert W. Baird | Analyst unavailable | $214 | $192.37 | +6.2% | Jul 16, 2026 |
| Wells Fargo | Analyst unavailable | $250 | $192.37 | +24.1% | Jul 16, 2026 |
| Goldman Sachs | Analyst unavailable | $231 | $192.37 | +14.6% | Jul 15, 2026 |
| UBS | Analyst unavailable | $228 | $168.85 | +13.2% | Mar 26, 2026 |
| Robert W. Baird | Andrew Wittmann | $250 | $198.34 | +24.1% | Mar 11, 2026 |
| Wells Fargo | Analyst unavailable | $245 | $192.72 | +21.6% | Jan 14, 2026 |
| UBS | Analyst unavailable | $235 | $188.31 | +16.6% | Dec 19, 2025 |
| Robert W. Baird | Analyst unavailable | $225 | $189.89 | +11.7% | Dec 19, 2025 |
| Wells Fargo | Analyst unavailable | $205 | $189.89 | +1.7% | Dec 19, 2025 |
| Morgan Stanley | Analyst unavailable | $210 | $188.45 | +4.2% | Dec 17, 2025 |
| Wells Fargo | Jason Haas | $185 | $182.16 | -8.2% | Nov 25, 2025 |
| Redburn Partners | Oliver Davies | $184 | $185.25 | -8.7% | Nov 11, 2025 |
| RBC Capital | Analyst unavailable | $206 | $202.05 | +2.2% | Sep 25, 2025 |
| Wells Fargo | Analyst unavailable | $218 | $202.05 | +8.2% | Sep 25, 2025 |
| Robert W. Baird | Analyst unavailable | $227 | $206.25 | +12.7% | Mar 27, 2025 |
| Truist Financial | Analyst unavailable | $230 | $204.71 | +14.1% | Mar 26, 2025 |
| Wells Fargo | Jason Haas | $184 | $183.03 | -8.7% | Dec 20, 2024 |
| Morgan Stanley | Toni Kaplan | $202 | $211.59 | +0.2% | Dec 12, 2024 |
| UBS | Joshua Chan | $240 | $210.39 | +19.1% | Sep 26, 2024 |
| Goldman Sachs | George Tong | $212 | $208.84 | +5.2% | Sep 25, 2024 |
| RBC Capital | Ashish Sabadra | $181 | $208.71 | -10.2% | Sep 25, 2024 |
| Wells Fargo | Jason Haas | $183.75 | $204.23 | -8.8% | Sep 24, 2024 |
| Truist Financial | Jasper Bibb | $225 | $203.77 | +11.7% | Sep 17, 2024 |
| CFRA | Caydee Blankenship | $170 | $203.8 | -15.6% | Sep 11, 2024 |
| Wells Fargo | Jason Haas | $183.75 | $189.91 | -8.8% | Aug 12, 2024 |
| Redburn Partners | Oliver Davies | $167.5 | $187.61 | -16.9% | Aug 9, 2024 |
| Truist Financial | Jasper Bibb | $212.5 | $189.64 | +5.5% | Jul 19, 2024 |
| Robert W. Baird | Andrew Wittmann | $193.75 | $190.73 | -3.8% | Jul 19, 2024 |
| RBC Capital | Ashish Sabadra | $181.25 | $171.76 | -10.0% | Mar 28, 2024 |
| Robert W. Baird | Andrew Wittmann | $197.5 | $171.16 | -2.0% | Mar 28, 2024 |
| Truist Financial | Jasper Bibb | $193.75 | $170.51 | -3.8% | Mar 28, 2024 |
| UBS | Joshua Chan | $197.5 | $171.41 | -2.0% | Mar 28, 2024 |
| Robert W. Baird | Andrew Wittmann | $187.5 | $171.41 | -6.9% | Mar 28, 2024 |
| Truist Financial | Analyst unavailable | $193.75 | $171.41 | -3.8% | Mar 27, 2024 |
| Stifel Nicolaus | Shlomo Rosenbaum | $146.25 | $158.67 | -27.4% | Mar 26, 2024 |
| Truist Financial | Jasper Bibb | $156.25 | $133.98 | -22.5% | Nov 13, 2023 |
| Argus Research | John Eade | $135 | $126.38 | -33.0% | Sep 26, 2023 |
| Morgan Stanley | Toni Kaplan | $32.69 | $29.03 | -83.8% | Mar 30, 2023 |
| Goldman Sachs | George Tong | $33.13 | $29.03 | -83.6% | Dec 21, 2022 |
| Morgan Stanley | Analyst unavailable | $23.31 | $24.26 | -88.4% | Sep 29, 2022 |
| Stifel Nicolaus | Shlomo Rosenbaum | $27.19 | $24.71 | -86.5% | Sep 28, 2022 |
| Morgan Stanley | Analyst unavailable | $22 | $24.3 | -89.1% | Sep 27, 2022 |
| Robert W. Baird | Analyst unavailable | $29.69 | $27.36 | -85.3% | Aug 17, 2022 |
| Morgan Stanley | Toni Kaplan | $22.63 | $24.18 | -88.8% | Jul 15, 2022 |
| Morgan Stanley | Analyst unavailable | $22.63 | $24.39 | -88.8% | Jul 15, 2022 |
| Deutsche Bank | Analyst unavailable | $29.06 | $23.05 | -85.6% | Jul 5, 2022 |
| Morgan Stanley | Analyst unavailable | $22.31 | $23.55 | -88.9% | May 26, 2022 |
| Deutsche Bank | Faiza Alwy | $129.25 | $105.97 | -35.9% | Apr 3, 2022 |
| Goldman Sachs | George Tong | $28.75 | $27.19 | -85.7% | Dec 23, 2021 |
| RBC Capital | Ashish Sabadra | $29.69 | $26.39 | -85.3% | Nov 30, 2021 |
| Stifel Nicolaus | Shlomo Rosenbaum | $23.63 | $24.09 | -88.3% | Oct 1, 2021 |
| Jefferies | Hamzah Mazari | $28 | $24.22 | -86.1% | Sep 29, 2021 |
| Credit Suisse | Kevin Mcveigh | $23.44 | $23.97 | -88.4% | Jul 16, 2021 |
Track every rating change on CTAS the moment it posts. Free to start.
Start free